Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Jul;115(5):767–774. doi: 10.1111/j.1476-5381.1995.tb14999.x

Evidence that [3H]-alpha,beta-methylene ATP may label an endothelial-derived cell line 5'-nucleotidase with high affinity.

A D Michel 1, N M Chau 1, T P Fan 1, E E Frost 1, P P Humphrey 1
PMCID: PMC1908513  PMID: 8548175

Abstract

1. In membranes prepared from a permanent cell line of endothelial origin (WEC cells), [3H]-alpha, beta-methylene ATP ([3H]-alpha, beta-meATP) labelled high (pKd = 9.5; Bmax = 3.75 pmol mg-1 protein) and low (pKd = 7.2; Bmax = 23.3 pmol mg-1 protein) affinity binding sites. The high affinity [3H]-alpha, beta-meATP binding sites in the WEC cell membranes could be selectively labelled with a low concentration of the radioligand (1 nM). In competition studies performed at a radioligand concentration of 1 nM, 88.6% of the sites possessed high affinity (pIC50 = 8.26) for alpha, beta-meATP. 2. The high affinity [3H]-alpha, beta-meATP binding sites appeared heterogeneous since in competition studies a number of nucleotide analogues (alpha, beta-meADP, ATP, ADP, AMP, GTP, GppNHp, GMP) and adenosine identified two populations of the sites labelled by 1 nM [3H]-alpha, beta-meATP. The proportion of sites with high affinity for these compounds was found to vary between 42 and 69%. 3. Approximately 60-69% of the binding sites labelled with 1 nM [3H]-alpha, beta-meATP possessed high affinity for alpha, beta-meADP (pIC50 = 8.87), AMP (pIC50 = 7.12), GMP (pIC50 = 7.34), UTP (pIC50 = 6.12), GTP (pIC50 = 7.59), GppNHp (pIC50 = 7.35) and adenosine (pIC50 = 5.45).(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
767

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bo X. N., Burnstock G. High- and low-affinity binding sites for [3H]-alpha, beta-methylene ATP in rat urinary bladder membranes. Br J Pharmacol. 1990 Oct;101(2):291–296. doi: 10.1111/j.1476-5381.1990.tb12703.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bo X., Simon J., Burnstock G., Barnard E. A. Solubilization and molecular size determination of the P2x purinoceptor from rat vas deferens. J Biol Chem. 1992 Sep 5;267(25):17581–17587. [PubMed] [Google Scholar]
  3. Boeynaems J. M., Pearson J. D. P2 purinoceptors on vascular endothelial cells: physiological significance and transduction mechanisms. Trends Pharmacol Sci. 1990 Jan;11(1):34–37. doi: 10.1016/0165-6147(90)90039-b. [DOI] [PubMed] [Google Scholar]
  4. Burger R. M., Lowenstein J. M. 5'-Nucleotidase from smooth muscle of small intestine and from brain. Inhibition of nucleotides. Biochemistry. 1975 Jun 3;14(11):2362–2366. doi: 10.1021/bi00682a014. [DOI] [PubMed] [Google Scholar]
  5. Burger R. M., Lowenstein J. M. Preparation and properties of 5'-nucleotidase from smooth muscle of small intestine. J Biol Chem. 1970 Dec 10;245(23):6274–6280. [PubMed] [Google Scholar]
  6. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol. 1985;16(5):433–440. doi: 10.1016/0306-3623(85)90001-1. [DOI] [PubMed] [Google Scholar]
  7. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  8. Cole O. F., Fan T. P., Lewis G. P. Isolation, characterisation, growth and culture of endothelial cells from the rat aorta. Cell Biol Int Rep. 1986 Jun;10(6):399–405. doi: 10.1016/0309-1651(86)90034-2. [DOI] [PubMed] [Google Scholar]
  9. Cooper C. L., Morris A. J., Harden T. K. Guanine nucleotide-sensitive interaction of a radiolabeled agonist with a phospholipase C-linked P2y-purinergic receptor. J Biol Chem. 1989 Apr 15;264(11):6202–6206. [PubMed] [Google Scholar]
  10. Edwards F. A., Gibb A. J., Colquhoun D. ATP receptor-mediated synaptic currents in the central nervous system. Nature. 1992 Sep 10;359(6391):144–147. doi: 10.1038/359144a0. [DOI] [PubMed] [Google Scholar]
  11. Evans W. H., Gurd J. W. Properties of a 5'-nucleotidase purified from mouse liver plasma membranes. Biochem J. 1973 May;133(1):189–199. doi: 10.1042/bj1330189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fedan J. S., Hogaboom G. K., O'Donnell J. P. Further comparison of contractions of the smooth muscle of the guinea-pig isolated vas deferens induced by ATP and related analogs. Eur J Pharmacol. 1986 Oct 7;129(3):279–291. doi: 10.1016/0014-2999(86)90438-3. [DOI] [PubMed] [Google Scholar]
  13. Fedan J. S., Hogaboom G. K., Westfall D. P., O'Donnell J. P. Comparison of contractions of the smooth muscle of the guinea-pig vas deferens induced by ATP and related nucleotides. Eur J Pharmacol. 1982 Jul 9;81(2):193–204. doi: 10.1016/0014-2999(82)90437-x. [DOI] [PubMed] [Google Scholar]
  14. Gordon E. L., Pearson J. D., Slakey L. L. The hydrolysis of extracellular adenine nucleotides by cultured endothelial cells from pig aorta. Feed-forward inhibition of adenosine production at the cell surface. J Biol Chem. 1986 Nov 25;261(33):15496–15507. [PubMed] [Google Scholar]
  15. Khakh B. S., Michel A., Humphrey P. P. Estimates of antagonist affinities at P2X purinoceptors in rat vas deferens. Eur J Pharmacol. 1994 Oct 3;263(3):301–309. doi: 10.1016/0014-2999(94)90726-9. [DOI] [PubMed] [Google Scholar]
  16. Mallol J., Bozal J. Modification of 5'-nucleotidase activity by divalent cations and nucleotides. J Neurochem. 1983 May;40(5):1205–1211. doi: 10.1111/j.1471-4159.1983.tb13558.x. [DOI] [PubMed] [Google Scholar]
  17. Michel A. D., Humphrey P. P. Distribution and characterisation of [3H]alpha,beta-methylene ATP binding sites in the rat. Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):608–617. doi: 10.1007/BF00167237. [DOI] [PubMed] [Google Scholar]
  18. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  19. Naito Y., Lowenstein J. M. 5'-Nucleotidase from rat heart membranes. Inhibition by adenine nucleotides and related compounds. Biochem J. 1985 Mar 15;226(3):645–651. doi: 10.1042/bj2260645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Naito Y., Lowenstein J. M. 5'-Nucleotidase from rat heart. Biochemistry. 1981 Sep 1;20(18):5188–5194. doi: 10.1021/bi00521a014. [DOI] [PubMed] [Google Scholar]
  21. Sun A. S., Holland J. F., Ohnuma T., Slankard-Chahinian M. 5'-nucleotidase activity in permanent human lymphoid cell lines. Implication for cell proliferation and aging in vitro. Biochim Biophys Acta. 1982 Feb 25;714(3):530–535. doi: 10.1016/0304-4165(82)90164-7. [DOI] [PubMed] [Google Scholar]
  22. Zimmermann H. 5'-Nucleotidase: molecular structure and functional aspects. Biochem J. 1992 Jul 15;285(Pt 2):345–365. doi: 10.1042/bj2850345. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES